Population-Level Impact of the Bivalent, Quadrivalent, and Nonavalent Human Papillomavirus Vaccines: A Model–Based Analysis - Wikidata - wikimedia - TriplyDB

Population-Level Impact of the Bivalent, Quadrivalent, and Nonavalent Human Papillomavirus Vaccines: A Model–Based Analysis

Population-Level Impact of the Bivalent, Quadrivalent, and Nonavalent Human Papillomavirus Vaccines: A Model–Based Analysis

http://www.wikidata.org/entity/Q57089346

about

The Interaction between Human Immunodeficiency Virus and Human Papillomaviruses in Heterosexuals in Africa Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis Durable immunity to oncogenic human papillomaviruses elicited by adjuvanted recombinant Adeno-associated virus-like particle immunogen displaying L2 17-36 epitopes Eurogin Roadmap 2015: How has HPV knowledge changed our practice: Vaccines.A portrait of single and multiple HPV type infections in Brazilian women of different age strata with squamous or glandular cervical lesions An updated natural history model of cervical cancer: derivation of model parameters.Pre-clinical immunogenicity of human papillomavirus alpha-7 and alpha-9 major capsid proteins Clinical effectiveness and cost-effectiveness of quadrivalent human papillomavirus vaccination in HIV-negative men who have sex with men to prevent recurrent high-grade anal intraepithelial neoplasia Vaccinating Girls and Boys with Different Human Papillomavirus Vaccines: Can It Optimise Population-Level Effectiveness?Comparison of two dose and three dose human papillomavirus vaccine schedules: cost effectiveness analysis based on transmission model Impact of vaccination on 14 high-risk HPV type infections: a mathematical modelling approach.Updating the PGMY primers and probes for improved detection of HPV68a: validation of version 2 of the PGMY-CHUV assay.Targeting human papillomavirus to reduce the burden of cervical, vulvar and vaginal cancer and pre-invasive neoplasia: establishing the baseline for surveillance.The impact of HPV female immunization in Italy: model based predictions.High-risk human papillomavirus in HIV-infected women undergoing cervical cancer screening in Lilongwe, Malawi: a pilot study.Anal Human Papillomavirus Genotyping among HIV-Positive Men Who Have Sex with Men in Xi'an, China Human papillomavirus vaccination: current indications and future directions Potential impact of a nonavalent HPV vaccine on the occurrence of HPV-related diseases in France.CDKN3 mRNA as a Biomarker for Survival and Therapeutic Target in Cervical Cancer Relationship between Humoral Immune Responses against HPV16, HPV18, HPV31 and HPV45 in 12-15 Year Old Girls Receiving Cervarix® or Gardasil® Vaccine HPV Genotypes distribution in Indian women with and without cervical carcinoma: Implication for HPV vaccination program in Odisha, Eastern India.Health economic evaluation of Human Papillomavirus vaccines in women from Venezuela by a lifetime Markov cohort model.Impact and Cost-effectiveness of 3 Doses of 9-Valent Human Papillomavirus (HPV) Vaccine Among US Females Previously Vaccinated With 4-Valent HPV Vaccine.Screening adolescents and young women Human papillomavirus infection and the multistage carcinogenesis of cervical cancer.Prevalence of Anal HPV Infection Among HIV-Positive Men Who Have Sex With Men in India.Impact of 2-, 4- and 9-valent HPV vaccines on morbidity and mortality from cervical cancer Human Papillomavirus (HPV) Infections and the Importance of HPV Vaccination.Amino acid sequence diversity of the major human papillomavirus capsid protein: implications for current and next generation vaccines.National- and state-level impact and cost-effectiveness of nonavalent HPV vaccination in the United States Impact of HPV vaccination on anogenital warts and respiratory papillomatosis Preventable fractions of cervical cancer via effective screening in six Baltic, central, and eastern European countries 2017-40: a population-based study.The road ahead for cervical cancer prevention and control.Impact of HPV immunization on the detection of cervical disease.The next generation of HPV vaccines: nonavalent vaccine V503 on the horizon.The cost-effectiveness of HPV vaccination in addition to screening: a Dutch perspective.The next steps in cervical screening.Extending the Human Papillomavirus Vaccination Programme to Include Males in High-Income Countries: A Systematic Review of the Cost-Effectiveness Studies.Mechanistic mathematical models: An underused platform for HPV research.Distribution of Vaccine-Type Human Papillomavirus Does Not Differ by Race or Ethnicity Among Unvaccinated Young Women.

P2860

Q26799584-7146FED0-1A34-4B38-BCD5-93197CF5D6D4 Q28084924-82163581-1298-447A-B06C-5BE54D31E7FC Q28603888-A9ED2944-9C38-4620-B2E0-CAB427E17D71 Q30251868-2B7A0BDD-D2FF-4FDB-8ED9-2263A07B658C Q33608013-A2873707-1547-442F-952B-A2408ACE39A5 Q34083083-0EE40B28-F56B-4CCD-9C69-86BDE3B37742 Q34492140-A3705203-5748-4D85-A56C-59522CF63145 Q34625933-9A1E010A-59B9-4EB5-9C66-8E2F11ACB913 Q34806423-D630CE7C-EDB6-45B4-8463-607C6E9074B3 Q34852567-7667B25E-9A49-4B3A-A3AF-996DBB4A11D6 Q34979497-2B1B52C5-9BBA-48F5-A27D-7CB06FD80E5C Q35036066-9604FB3F-5D5B-448B-B358-330C30610A58 Q35088687-FCF56149-3732-4761-B344-8453530FBF7B Q35117850-A78AB26D-2292-4A18-8E35-8CDF663B443A Q35186321-80EC9ABF-D076-44D1-B678-A2E7FA04C04D Q35553220-95AA445C-AB95-482C-8A2F-A1F894923AAD Q35558593-3B1D8BCC-A618-4020-BF8D-E20CC2235FE3 Q35610248-6B7C0B11-A6DA-4636-BAAF-EDEF65C3C298 Q35776083-A9D8A894-1847-4E42-BAFF-9465618DA9E6 Q35818648-763BAD9B-B420-4177-9F67-C71939B887AF Q36240830-F70602CF-7631-4461-948D-353AC76F34E9 Q36266671-CB6F6618-C819-4FB9-94C3-8001C19056FC Q36871974-A634CD67-F38D-4A73-8D75-49E5D432E1CD Q36903551-5CCC93D0-C887-4C2E-9492-5F3F66F50DA0 Q37013482-F21DDE4B-C320-45FA-80FE-75AEC966255E Q37080479-6DCA574C-011B-4E8B-AD64-72FE211F8D47 Q37135163-E4D43F53-A0AB-4D20-9562-EB4DED1EDC45 Q37155765-BB59D29F-BFA8-45E5-BE2C-7280D7956190 Q37162220-2EA7BC1F-8166-4446-A6E9-13E51D155D65 Q37173134-28BE69E2-181F-44B0-8A3F-577885FB3B96 Q37284313-C9E6999B-2AE9-4532-92EE-A461949543F3 Q37314466-FB7BB17A-0D49-4FF8-81BD-291E00F971D8 Q37719631-70559159-65E2-4B2F-9E91-FD7AB47DB49F Q38194249-F96910E8-70AA-4510-BE1A-BA1DBFE19BA1 Q38254337-A1B2A308-8056-49B9-A53E-33416D339986 Q38284334-282142EF-43C4-446A-9927-26197419089C Q38380092-3B090769-B6FD-4022-9DAA-F6929FD48160 Q38549643-8F764E16-249D-40BB-957A-01AD5D9A7557 Q38673360-09510F67-8920-46FC-BB22-C7C816F292D8 Q38984023-B68254B0-6014-4258-9114-22398365DD6A

P2860

Population-Level Impact of the Bivalent, Quadrivalent, and Nonavalent Human Papillomavirus Vaccines: A Model–Based Analysis

http://www.wikidata.org/entity/Q57089346

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Population-Level Impact of the ...... ccines: A Model–Based Analysis

@en

Population-Level Impact of the ...... ccines: A Model–Based Analysis

@nl

type

label

Population-Level Impact of the ...... ccines: A Model–Based Analysis

@en

Population-Level Impact of the ...... ccines: A Model–Based Analysis

@nl

prefLabel

Population-Level Impact of the ...... ccines: A Model–Based Analysis

@en

Population-Level Impact of the ...... ccines: A Model–Based Analysis

@nl

P1433

Q57089346-07F80362-EE89-4CAE-9D74-0ED37689876E

P1476

Q57089346-76134A1D-DE2D-44EC-87C2-A4E96A5881B6

P2093

Q57089346-0AC6A38E-AF51-4579-9AEF-4F9872301936

Q57089346-534D8FEC-2FAD-47F6-8E06-E55B91ACB317

Q57089346-5464FDCB-7796-4DC1-A828-C970CCAFFDFE

Q57089346-6218CAE6-F495-4DD5-B929-EEDB1EBA0FF2

Q57089346-8D773E56-BBA4-45C4-994D-84B6A730C567

Q57089346-8EEF74C4-7595-4A79-B71A-17D00EFDCEE4

Q57089346-D6B454F1-0F30-4AB6-AFB4-D99DE6D12158

Q57089346-D79C4180-F5FF-43E4-AB73-9B15212FEF1C

P2860

Q57089346-0A990E94-D8EF-4C30-A8F7-5B954FD97977

Q57089346-17481590-B4FA-4874-8734-DA2526F9962B

Q57089346-1CC559A9-F20F-40DD-A6B5-150BCB69924C

Q57089346-1D9DDC5D-D398-4959-8C63-93234A3DEA87

Q57089346-21FF8491-683D-41D1-B992-071CADC22A75

Q57089346-2583F59B-A456-4C58-8C4C-BF939E0CA932

Q57089346-2C281A32-F9B6-420A-B457-D6297849F454

Q57089346-33145A24-9E73-4F88-A456-3C5CE3A1D7EC

Q57089346-3C9E7174-5BF1-427F-B745-76D53AA650C3

Q57089346-44519C4B-301A-4AC9-941B-602514219BDD

P304

Q57089346-017ABC98-A830-4120-BD47-378CA1BB61B1

P31

Q57089346-189F7050-FF2A-46F5-9B5E-1243391D9188

P356

Q57089346-5F87623A-C855-450F-AA3F-EFFFFF198541

P407

Q57089346-45748A1B-B282-4A82-B607-2F159BCFD8E1

P433

Q57089346-490ACBE5-A5B9-47F2-81C3-C409359C9EE6

P478

Q57089346-BBC92CC8-5D00-426C-983C-E24D1B7D97DC

P50

Q57089346-3D105F51-1189-4D64-9DA3-24E5B99D9B2A

Q57089346-593327EF-9434-46DD-8368-D54895DFE0F8

P577

Q57089346-6227A968-12B8-431F-9A38-10CEEFCF802B

P698

Q57089346-4BF288D6-2889-4C5E-8BBF-60C6BA88B0FB

P356

P1433

Journal of the National Cancer Institute

P1476

Population-level impact of the ...... ccines: a model-based analysis

@en

P2093

Erich V Kliewer

http://www.w3.org/2001/XMLSchema#string

François Coutlée

http://www.w3.org/2001/XMLSchema#string

Jean-François Laprise

http://www.w3.org/2001/XMLSchema#string

Marc Brisson

http://www.w3.org/2001/XMLSchema#string

Marie-Hélène Mayrand

http://www.w3.org/2001/XMLSchema#string

Mélanie Drolet

http://www.w3.org/2001/XMLSchema#string

Nicolas Van de Velde

http://www.w3.org/2001/XMLSchema#string

Talía Malagón

http://www.w3.org/2001/XMLSchema#string

P2860

Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions

Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis

A review of human carcinogens--Part B: biological agents

Epidemiologic classification of human papillomavirus types associated with cervical cancer

Classification of papillomaviruses

Estimating progression rates for human papillomavirus infection from epidemiological data.

Cost-effectiveness of different human papillomavirus vaccines in Singapore

Sexual behaviour in context: a global perspective.

P304

1712-1723

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JNCI/DJS395

http://www.w3.org/2001/XMLSchema#string

P407

P433

22

http://www.w3.org/2001/XMLSchema#string

P478

104

http://www.w3.org/2001/XMLSchema#string

P50

Eduardo L. Franco

Marie-Claude Boily

P577

2012-10-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23104323

http://www.w3.org/2001/XMLSchema#string